×
About 57,174 results

ALLMedicine™ Psoriasis Center

Research & Reviews  24,515 results

Prevalence and factors associated with depression and anxiety in patients with psoriasis.
https://doi.org/10.1111/jocn.15577
Journal of Clinical Nursing; Pollo CF, Miot HA et. al.

Dec 1st, 2020 - To identify the prevalence and factors associated with depression and anxiety in patients with psoriasis BACKGROUND: Psoriasis is a chronic, non-contagious, autoimmune inflammatory skin disease associated with psychological comorbidities. A cross-...

Protective Effects of Anti-depressants against the Subsequent Development of Psoriasis ...
https://doi.org/10.1016/j.jad.2020.11.110
Journal of Affective Disorders; Tzeng YM, Li IH et. al.

Dec 1st, 2020 - Inflammation may mediate the relationship between major depressive disorder (MDD) and psoriasis. However, it is unclear whether anti-depressants can decrease the subsequent risk of psoriasis among MDD patients. This study investigated the effects ...

Pulmonary function severity in relation to interleukin-23 levels in patients with psori...
https://doi.org/10.1515/jbcpp-2019-0229
Journal of Basic and Clinical Physiology and Pharmacology; Saranya V, Kuppusamy S et. al.

Dec 1st, 2020 - Background Interleukin-23 (IL-23), a key inflammatory regulator in the pathogenesis of psoriasis, is suspected to play a role in the onset of pulmonary dysfunction (chronic obstructive pulmonary disease) in psoriasis. Despite that, pulmonary funct...

Guselkumab: the first selective IL-23 inhibitor for active psoriatic arthritis in adults.
https://doi.org/10.1080/1744666X.2020.1857733
Expert Review of Clinical Immunology; Boehncke WH, Brembilla NC et. al.

Nov 30th, 2020 - Guselkumab is a subcutaneously administered human monoclonal antibody, selectively blocking IL-23 through binding to its p19 subunit. It was initially approved for the treatment of patients with moderate-to-severe plaque-psoriasis who are candidat...

Bone morphogenetic protein signaling regulates skin inflammation via modulating dendrit...
https://doi.org/10.1016/j.jaci.2020.09.038
The Journal of Allergy and Clinical Immunology; Sconocchia T, Hochgerner M et. al.

Nov 30th, 2020 - Bone morphogenetic proteins (BMPs) are members of the TGF-β family that signal via the BMP receptor (BMPR) signaling cascade, distinct from canonical TGF-β signaling. BMP downstream signaling is strongly induced within epidermal keratinocytes in c...

see more →

Guidelines  187 results

Risk of osteoarthritis in an incident cohort of people with psoriatic arthritis: a population-based cohort study
https://www.jrheum.org/content/early/2020/11/10/jrheum.200564
The Journal of Rheumatology; Charlton R

Nov 15th, 2020 - To determine the risk of a diagnosis of osteoarthritis (OA) in psoriatic arthritis (PsA) patients compared to patients with psoriasis and a general population cohort.

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 4th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

Evaluation of the correlation between scales determining disease severity in patients with moderate-severe chronic plaque type psoriasis
https://pubmed.ncbi.nlm.nih.gov/33142051/
Journal of Cosmetic Dermatology; Gundogdu M

Nov 2nd, 2020 - Psoriasis is a chronic erythematous-squamous disease. The results of studies related with the correlation between methods used in determining disease severity are contradictory.

Cardiovascular risk in patients with plaque psoriasis and psoriatic arthritis without a clinically overt cardiovascular disease: the role of endothelial progenitor cells
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394160/
Postepy Dermatol Alergol; Michalska

Jul 13th, 2020 - Psoriasis is an autoimmune, chronic disease determined by environmental and genetic factors. The occurrence of psoriasis is accompanied by metabolic diseases, cardiovascular diseases (CVD) and depression, disturbances on interpersonal interactions...

Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7211212/
Rheumatology and Therapy; Dal Bello G

Apr 16th, 2020 - Psoriatic arthritis (PsA) is a chronic immune-mediated inflammatory spondyloarthropathy associated with psoriasis. PsA is frequently associated with metabolic disorders including, obesity, metabolic syndrome, and diabetes mellitus (DM). Type 2 DM ...

see more →

Drugs  1,253 results see all →

Clinicaltrials.gov  27,295 results

Prevalence and factors associated with depression and anxiety in patients with psoriasis.
https://doi.org/10.1111/jocn.15577
Journal of Clinical Nursing; Pollo CF, Miot HA et. al.

Dec 1st, 2020 - To identify the prevalence and factors associated with depression and anxiety in patients with psoriasis BACKGROUND: Psoriasis is a chronic, non-contagious, autoimmune inflammatory skin disease associated with psychological comorbidities. A cross-...

Protective Effects of Anti-depressants against the Subsequent Development of Psoriasis ...
https://doi.org/10.1016/j.jad.2020.11.110
Journal of Affective Disorders; Tzeng YM, Li IH et. al.

Dec 1st, 2020 - Inflammation may mediate the relationship between major depressive disorder (MDD) and psoriasis. However, it is unclear whether anti-depressants can decrease the subsequent risk of psoriasis among MDD patients. This study investigated the effects ...

Pulmonary function severity in relation to interleukin-23 levels in patients with psori...
https://doi.org/10.1515/jbcpp-2019-0229
Journal of Basic and Clinical Physiology and Pharmacology; Saranya V, Kuppusamy S et. al.

Dec 1st, 2020 - Background Interleukin-23 (IL-23), a key inflammatory regulator in the pathogenesis of psoriasis, is suspected to play a role in the onset of pulmonary dysfunction (chronic obstructive pulmonary disease) in psoriasis. Despite that, pulmonary funct...

Guselkumab: the first selective IL-23 inhibitor for active psoriatic arthritis in adults.
https://doi.org/10.1080/1744666X.2020.1857733
Expert Review of Clinical Immunology; Boehncke WH, Brembilla NC et. al.

Nov 30th, 2020 - Guselkumab is a subcutaneously administered human monoclonal antibody, selectively blocking IL-23 through binding to its p19 subunit. It was initially approved for the treatment of patients with moderate-to-severe plaque-psoriasis who are candidat...

Bone morphogenetic protein signaling regulates skin inflammation via modulating dendrit...
https://doi.org/10.1016/j.jaci.2020.09.038
The Journal of Allergy and Clinical Immunology; Sconocchia T, Hochgerner M et. al.

Nov 30th, 2020 - Bone morphogenetic proteins (BMPs) are members of the TGF-β family that signal via the BMP receptor (BMPR) signaling cascade, distinct from canonical TGF-β signaling. BMP downstream signaling is strongly induced within epidermal keratinocytes in c...

see more →

News  3,703 results

Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years
https://www.staging.medscape.com/viewarticle/941377

Nov 19th, 2020 - The full 5-year results of a long-term extension study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5,400 patient-years of prospective follow-up, Diamont Thaç...

Tildrakizumab for Psoriasis Shows Durable Efficacy Over 5 Years
https://www.medscape.com/viewarticle/941377

Nov 19th, 2020 - The full 5-year results of a long-term extension study of tildrakizumab for psoriasis show a high rate of sustained disease control coupled with a favorable safety profile during more than 5,400 patient-years of prospective follow-up, Diamont Thaç...

Risk of osteoarthritis in an incident cohort of people with psoriatic arthritis: a population-based cohort study
https://www.jrheum.org/content/early/2020/11/10/jrheum.200564
The Journal of Rheumatology; Charlton R

Nov 15th, 2020 - To determine the risk of a diagnosis of osteoarthritis (OA) in psoriatic arthritis (PsA) patients compared to patients with psoriasis and a general population cohort.

Chronic Inflammatory Diseases Vary Widely in CHD Risk
https://www.medscape.com/viewarticle/941045

Nov 15th, 2020 - Not all chronic systemic inflammatory diseases are equal enhancers of atherosclerotic cardiovascular disease risk, according to a large case-control study. Current AHA/American College of Cardiology guidelines cite three chronic inflammatory disea...

Topical Tapinarof Effective in Pivotal Psoriasis Trials
https://www.medscape.com/viewarticle/940526

Nov 5th, 2020 - Tapinarof cream 1% applied once daily in patients with plaque psoriasis convincingly hit its primary and secondary endpoints and was well tolerated in two identical pivotal phase 3, randomized trials, Mark G. Lebwohl, MD, reported at the virtual a...

see more →

Patient Education  221 results see all →